TXG - 10x Genomics, Inc.
10x Genomics, Inc. , a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products.
As of May 15, 2026: spot at $21.18, ATM IV 75.1%, net GEX $51.7K.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Market Cap
- $2.67B
- Beta
- 2.05
- 52-Week Range
- 8.065-26.445
- CEO
- Serge Saxonov
- Employees
- 1,306
- IPO Date
- Sep 12, 2019
- Exchange
- NASDAQ
What TXG Looks Like to Options Traders Today
IV rank of 29.4% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); positive net gamma exposure ($51.7K) means dealers hedge against trend, damping realized volatility and biasing price toward heavy-OI strikes; the 25-delta skew (0.110) prices calls richer than puts, often reflecting upside speculation or squeeze risk.
What This Page Covers
The TXG overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked TXG overview questions
- What is TXG?
- TXG is the ticker symbol for 10x Genomics, Inc., a listed security. 10x Genomics, Inc. , a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. Listed on NASDAQ. TXG is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the TXG options snapshot look like today?
- As of May 15, 2026, the TXG options snapshot shows spot at $21.18, ATM IV 75.1%, IV rank 29.4%, net GEX $51.7K, expected move 21.53%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are TXG's key statistics?
- 10x Genomics, Inc. (TXG) carries a market capitalization of $2.67B, beta of 2.05 relative to the broader market, 52-week range of 8.065-26.445. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does TXG belong to?
- 10x Genomics, Inc. operates in the Healthcare sector, in the Medical - Healthcare Information Services industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare TXG's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the TXG data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).